Chengdu Easton Biopharmaceuticals Co., Ltd. Class ASSE: 688513

"Chengdu Easton Biopharmaceuticals Co., Ltd."Announcement on Voluntary Disclosure of Progress of Phase I Clinical Trials for EP-0226 Tablets

· Issued by Chengdu Easton Biopharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Progress of Phase I Clinical Trials for EP-0226 Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Chengdu Easton Biopharmaceuticals Co., Ltd. Class A

All Chengdu Easton Biopharmaceuticals Co., Ltd. Class A news releases